Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001477932-25-002577
Filing Date
2025-04-10
Accepted
2025-04-10 13:44:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 15566
  Complete submission text file 0001477932-25-002577.txt   17313
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Subject) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89724 | Film No.: 25827699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 27TH FLOOR NEW YORK NY 10105 212-813-1010
Pembroke & Partners LLC (Filed by) CIK: 0002056785 (see all company filings)

EIN.: 333245110 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A